Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis in Myocardial Infarction 48 (ENGAGE AF–TIMI 48) trial
Titel:
Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis in Myocardial Infarction 48 (ENGAGE AF–TIMI 48) trial
Auteur:
Eisen, Alon Giugliano, Robert P. Ruff, Christian T. Nordio, Francesco Gogia, Harinder S. Awasty, Vivek R. Henderson, David A. Mercuri, Michele F. Rutman, Howard Antman, Elliott M. Braunwald, Eugene